Skip to Content
Merck
  • Generation of human iPSC-derived phrenic-like motor neurons to model respiratory motor neuron degeneration in ALS.

Generation of human iPSC-derived phrenic-like motor neurons to model respiratory motor neuron degeneration in ALS.

Communications biology (2024-02-29)
Louise Thiry, Julien Sirois, Thomas M Durcan, Stefano Stifani
ABSTRACT

The fatal motor neuron (MN) disease Amyotrophic Lateral Sclerosis (ALS) is characterized by progressive MN degeneration. Phrenic MNs (phMNs) controlling the activity of the diaphragm are prone to degeneration in ALS, leading to death by respiratory failure. Understanding of the mechanisms of phMN degeneration in ALS is limited, mainly because human experimental models to study phMNs are lacking. Here we describe a method enabling the derivation of phrenic-like MNs from human iPSCs (hiPSC-phMNs) within 30 days. This protocol uses an optimized combination of small molecules followed by cell-sorting based on a cell-surface protein enriched in hiPSC-phMNs, and is highly reproducible using several hiPSC lines. We show further that hiPSC-phMNs harbouring ALS-associated amplification of the C9orf72 gene progressively lose their electrophysiological activity and undergo increased death compared to isogenic controls. These studies establish a previously unavailable protocol to generate human phMNs offering a disease-relevant system to study mechanisms of respiratory MN dysfunction.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-Pax6 Antibody, clone AD1.5, ascites fluid, clone AD1.5, Chemicon®
Sigma-Aldrich
Valproic acid sodium salt, 98%
Sigma-Aldrich
DMH1, ≥98% (HPLC)
Sigma-Aldrich
γ-Secretase Inhibitor XXI, Compound E, This g-secretase inhibitor, CAS 209986-17-4, is a cell-permeable, potent, selective, non-transition-state analog inhibitor of γ-secretase and Notch processing. Lowers Aβ levels in APP transgenic mice
Sigma-Aldrich
Anti-Olig2 Antibody, clone 211F1.1, clone 211F1.1, from mouse